Jay Zhang is the Co-Founder and President of TriArm Therapeutics, a clinical-stage cell therapy company. A Venture Partner at Panacea Venture, he holds a Ph. D. from the University of Utah and completed postdoctoral training at Stanford University. His mission is to make advanced CAR-T therapies more accessible and affordable globally.
Jay views life science and business through an artistic lens, believing them to be among the most beautiful forms of art. He is passionate about turning the business of life sciences into a masterpiece, moving beyond the simple mechanics of cells and DNA to a more profound appreciation of the field.
He believes that life is the most beautiful art in the universe.
Jay Zhang
President at TriArm Therapeutics
San Mateo, California, United States
Overview
Topics They Care About
CAR-T Democratization
He is on a mission to make CAR T therapies more accessible and affordable for patients worldwide, addressing current limitations of cost and manufacturing time.
Non-Viral Gene Therapy
His company, TriArm, focuses on a non-viral gene transfer platform to develop safer, next-generation cell therapies with significantly reduced manufacturing time.
Biopharma Venture Capital
As a Venture Partner with Panacea Venture, he is involved in identifying and nurturing innovative healthcare and life science companies.
Media Appearances
Jay has no verified media appearances
Work History
9-2024
President at TriArm Therapeutics
7-2019
Chief Executive Officer at Tactiva Therapeutics Inc
10-2018 - 10-2024
Chief Executive Officer at TriArm Therapeutics Limited
1-2018
Venture Partner at Panacea Venture Healthcare
9-2013 - 9-2018
General Manager at Dragonboat Biopharmaceutics Co., Ltd
Education
9-1999 - 8-2002
Postdoc from Stanford University
9-1993 - 3-1999
Ph.D from University of Utah
More Information
Social Presence :
Prographics :
Exp : 12
Location : San Mateo, California, United States
Job Level : Leadership
Designation : President at TriArm Therapeutics
